RDY
Dr. Reddy's Laboratories Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$14.74
+3.04%Margins
Gross margin
49.5%
EBITDA margin
16.3%
EBIT margin
8.9%
Net margin
8.5%
FCF margin
3.6%
7.2%
Return on equity
4.9%
Return on assets
6.4%
Return on invested capital
0.58x
Asset turnover
$317.6M
Cash from operations
$0.97
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026